通过调解BAP1的在位依赖性退化,VCP促进胆管癌的发展
Peiying Zhang1, Xiangning Liu1, Yue Liu1
1Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Cancer science
|March 23, 2025
概括
研究人员确定了含有瓦洛辛的蛋白质 (VCP) 作为胆管癌 (CCA) 治疗的目标. 阻断VCP通过阻止瘤抑制剂BAP1的降解来抑制瘤生长,为CCA提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 胆管癌 (CCA) 是一种高度恶性癌症,有效的治疗选择有限.
- 目前针对CCA的向疗法,如佩米加替尼和伊沃西登尼,仅对具有特定突变 (FGFR,IDH1/2) 的小组患者 (~30%) 有好处.
- BAP1瘤抑制剂的下调在CCA中很常见,并且与预后不佳有关,需要新的治疗策略.
研究的目的:
- 为了研究BAP1在胆管癌中抑制瘤的作用.
- 为了确定CCA中BAP1蛋白质稳态的上游调节者.
- 评估在CCA治疗中准VCP (含瓦洛辛蛋白) 的治疗潜力.
主要方法:
- 在CCA模型中证明了BAP1的瘤抑制功能.
- 确定了VCP作为BAP1蛋白水平的关键调节者.
- 通过ubiquitin-proteasome途径研究了VCP介导的BAP1降解的机制.
- 评估了CCA细胞系中VCP抑制剂的抗瘤作用.
主要成果:
- VCP与BAP1结合,通过ubiquitin-proteasome通路促进其无化和降解,这驱动了CCA细胞的增殖并抑制了细胞亡.
- 抑制VCP阻断了BAP1降解,导致CCA细胞生长减少和亡增加.
- 这些发现阐明了CCA中BAP1下调的新机制.
结论:
- 在CCA中BAP1的异常低表达是由VCP诱导的降解介导的.
- 在CCA中,VCP作为BAP1蛋白质恒温的关键上游调节器.
- VCP 抑制剂通过恢复 BAP1 水平在 CCA 中表现出抗瘤功效,使 VCP 成为 CCA 的有希望的治疗标.
相关概念视频
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
The Intrinsic Apoptotic Pathway
5.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Separation of Sister Chromatids
3.5K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


